Search results
Showing 691 to 700 of 829 search results for senior managers regime.
-
TR19/3: Review of the fair treatment of with-profits customers
We commenced our review with an assessment of all the areas across the with-profits market where there is potential for customer harm. After identifying those areas we regard as presenting the highest potential for customer harm, we conducted a -
PS23/16: Sustainability Disclosure Requirements (SDR) and investment labels
We set out our final rules and guidance to help consumers navigate the market for sustainable investment products. -
Investment managers still failing to ensure effective oversight of best execution
We outline findings from supervisory work looking at how investment managers deliver best execution for their clients. -
The FCA’s approach to Brexit: our preparations and our vision for the future
Speech delivered by Nausicaa Delfas, Executive Director of International at the FCA, at Bloomberg/TheCityUK. -
Building a financial regulatory system suitable for the UK in the new era
Speech delivered by Nausicaa Delfas, Executive Director of International, at the City & Financial Professional Virtual Roundtables. -
Primary Market Bulletin Issue No. 29
In this special edition, we publish a statement on feedback we received from PMB25 and the changes we have made in response. We also include the final note. -
Critical issues in financial regulation: The FCA's perspective
Speech by our CEO, Nikhil Rathi, delivered at City Week 2022. -
FCA sets out multi-occupancy leasehold insurance reforms
The FCA is proposing new rights and protections for leaseholders to improve the transparency of the multi-occupancy leasehold buildings insurance market. -
PS18/17: The European Money Market Funds (MMF) Regulation
In this Policy Statement, we respond to feedback arising from CP18/4 and publish final rules amending our Handbook to ensure consistency with the requirements of the EU Money Market Funds (MMF) Regulation. We also apply fee schedules to enable us -
FS20/2: Patient Capital and Authorised Funds
This Feedback Statement summarises responses from DP18/10 on whether there are unnecessary barriers to investing in patient capital through authorised funds.